← Leaderboards
Roy R Swiger
Acenxion Biosystems, Inc.
$2,934,394
Attributed
$2,934,394
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2021–23$1M$750K$500K$250K$0
'21
'22
'23
Funding mix
By agency
NIH$2,934,394 · 1
By mechanism
R44$2,934,394 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Agreement”
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Jerene Shaheed · Administrative Resource Center, Treasury Franchise Services$77,493,783
- Julie Ake · National Institute Of Allergy And Infectious Diseases$50,742,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$46,590,142
- Claudia Valmonte · The Emmes Company, Llc$38,115,589
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
Research focus
AgreementEnsureAntibioticsAntibiotic SusceptibilityAgarAntimicrobial ResistanceBacteriaBaseBehaviorCarbon DioxideAntibiotic TherapyAnatomyClinical ResearchCodeCo-InfectionCommercializationComputersComputer SoftwareContractsCostData AnalysesDesignDevicesEnvironment
Grant awards (3)
An automated, scalable, and rapid AST system for Gonorrhea STIs$1,000,000
R44 · FY2023 · AI · contact PI
An automated, scalable, and rapid AST system for Gonorrhea STIs$967,307
R44 · FY2022 · AI · contact PI
An automated, scalable, and rapid AST system for Gonorrhea STIs$967,087
R44 · FY2021 · AI · contact PI